Diego O. Andrey
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 20
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 12
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 detection and testing 7
- Endocrinology top 5%
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 5
-
- Bacterial biofilms and quorum sensing 8
-
- Pharmaceutical and Antibiotic Environmental Impacts 5
Diego O. Andrey
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Molecular Medicine 279
- Infectious Diseases 615
- Applied Microbiology and Biotechnology 38
- Endocrinology 83
- Clinical Biochemistry 87
Countries citing papers authored by Diego O. Andrey
This map shows the geographic impact of Diego O. Andrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego O. Andrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego O. Andrey more than expected).
Fields of papers citing papers by Diego O. Andrey
This network shows the impact of papers produced by Diego O. Andrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego O. Andrey. The network helps show where Diego O. Andrey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diego O. Andrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 73 | |
| 11 | 2021 | 48 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 25 | |
| 14 | 2020 | 43 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 2 | |
| 17 | 2015 | 0 | |
| 18 | 2012 | 54 | |
| 19 | 2011 | 60 | |
| 20 | 2009 | 9 |
About Diego O. Andrey
Diego O. Andrey is a scholar working on Molecular Medicine, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Antimicrobial Resistance in Staphylococcus (12 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Bacterial biofilms and quorum sensing (8 papers), COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 detection and testing (7 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (5 papers). The work is most often cited by research in Molecular Medicine (279 citations), Infectious Diseases (615 citations) and Applied Microbiology and Biotechnology (38 citations). Diego O. Andrey has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include William L. Kelley, Antoinette Monod, Adriana Renzoni, Laurent Kaiser, Ambre Jousselin, Ambrose L. Cheung, Roberto Sierra, Mélanie Roch, Timothy R. Walsh and Nicolas Vuilleumier.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.